Ovatech completes Phase 2 study of Ovaprene non-hormonal, intravaginal contraceptiveInformation on Ovatech completes Phase 2 study of Ovaprene non-hormonal, intravaginal contraceptive under Hormonal section of the Health Articles & Reviews; Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully ... |
![]() |
|
Ovatech completes Phase 2 study of Ovaprene non-hormonal, intravaginal contraceptive
by Haddasah_Milovsky 09-03-2010, 05:29 PM
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal ...
More... |
|
Views 11
Comments 0
|
![]() |
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |